Clinical Trials Browser

Phase 2 × Interventional × naptumomab estafenatox × Clear all

NCT04880863 2025-03-03

NT-NAP-102-1

Phase 2 Completed

38 enrolled 13 charts

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis